Penneo - Intensified Growth Investments
2022-06-01 09:45:00
Redeye retains its positive view of Penneo following its Q1 report. The FY’22 ARR guidance was maintained, while the EBITDA guided range was adjusted to a negative of DKK 15-20m (earlier neg. DKK 5-10m) due to intensified growth investments. Consequently, we will make minor 2022E and 2023E forecast adjustments while raising the WACC due to an increased risk-free rate, affecting our valuation to some extent
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/